PathologybioRxivPreprint
Nanocarrier-driven dual targeting VCAM-1/Collagen IV enables RNA interference-mediated silencing of Smad3 and Runx2 to mitigate aortic valve disease
Geanina Voicu, Cristina Ana Mocanu, Florentina Safciuc…·Manuela Călin
This study develops dual-targeted nanocarriers to deliver shRNA against Smad3 and Runx2, reducing aortic valve calcification in a mouse model.